Obama's Trip To India To Focus On Trade Issues, Possibly Drug Making
This article was originally published in PharmAsia News
Executive SummaryIndia's mulling whether to apply compulsory licensing to foreign drug makers and dealing with healthcare trade differences with the United States are expected to be areas of concern during U.S. President Barack Obama's upcoming visit
You may also be interested in...
The US Patent Office has rejected a request by Edwards LifeSciences to review an Abbott patent on heart-valve technology, which could establish the patent as a key part of Abbott Laboratories’ arguments in a larger ongoing intellectual property case.
The World Health Organization has proposed changes to its 2016 guideline on data integrity requirements to provide streamlined information to sponsors and to take account of experience gained to date.